In Reply: Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results from a Randomized Controlled Trial-Reference-Cited by-同舟云学术

In Reply: Does a Screening Trial for Spinal Cord Stimulation in Patients With Chronic Pain of Neuropathic Origin Have Clinical Utility (TRIAL-STIM)? 36-Month Results from a Randomized Controlled Trial

Published:2024-03-22 Issue: Volume: Page:
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Eldabe Sam¹,Nevitt Sarah²³,Griffiths Sara¹,Gulve Ashish¹,Thomson Simon⁴,Baranidharan Ganesan⁵,Houten Rachel³⁶,Brookes Morag¹,Kansal Anu¹,Earle Jenny⁷,Bell Jill⁷,Taylor Rod S.⁸,Duarte Rui V.³⁹

Affiliation:

1. Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK

2. Centre for Reviews and Dissemination, University of York, York, UK

3. Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK

4. Pain Medicine and Neuromodulation, Mid & South Essex University Hospitals, Essex, UK

5. Leeds Neuromodulation Centre, Leeds Teaching Hospitals, Leeds, UK

6. Health Economics, QC Medica, Liverpool, UK

7. Patient and Public Involvement Representatives, Middlesbrough, UK

8. MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, Glasgow, UK

9. Saluda Medical Pty Ltd, Artarmon, New South Wales, Australia

Funder

National Institute for Health and Care Research

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference6 articles.

1. Letter: Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility (TRIAL-STIM)? 36-month results from a randomized controlled trial;Zhou;Neurosurgery.,2023

2. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility (TRIAL-STIM)? 36-month results from a randomized controlled trial;Eldabe;Neurosurgery.,2023

3. Trial versus no trial of spinal cord stimulation for chronic neuropathic pain: cost analysis in United Kingdom National Health Service;Duarte;Neuromodulation.,2019

4. Does a screening trial for spinal cord stimulation in patients with chronic pain of neuropathic origin have clinical utility and cost-effectiveness (TRIAL-STIM)? A randomised controlled trial;Eldabe;Pain.,2020

5. Screening trials of spinal cord stimulation for neuropathic pain in England—a budget impact analysis;Duarte;Front Pain Res (Lausanne).,2022